Metastatic Hepatic Epithelioid Hemangio-Endothelioma: Long-Term Response to Sunitinib Malate

Publisher： Karger

E-ISSN： 2296-5262|37|3|124-126

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.3, 2014-02, pp. : 124-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epithelioid Hemangioendothelioma of the Kidney Treated with Sunitinib

By  

Oncology Research and Treatment, Vol. 35, Iss. 6, 2012-05 ,pp. : 376-378

Karger

Access to resources Recommend Favorite

Metastatic Pulmonary Epithelioid Hemangioendothelioma with Peculiar Radiographic Features

By  

Respiration, Vol. 66, Iss. 1, 1999-02 ,pp. : 78-80

Karger

Access to resources Recommend Favorite

Sorafenib Monotherapy in a Patient with Unresectable Hepatic Epithelioid Hemangioendothelioma

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-02 ,pp. : 134-137

Karger

Access to resources Recommend Favorite

Thalidomide Inhibits the Growth and Progression of Hepatic Epithelioid Hemangioendothelioma

By  

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 471-475

Karger

Access to resources Recommend Favorite

Targeting VEGF-VEGFR Pathway by Sunitinib in Peripheral Primitive Neuroectodermal Tumor, Paraganglioma and Epithelioid Hemangioendothelioma: Three Case Reports

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-02 ,pp. : 90-97

Karger

Access to resources Recommend Favorite